Many young adults use e-cigarettes in addition to smoking traditional cigarettes, a dual-use risk that increases long-term health risks.
New research led by Klemperer reveals an effective approach for young adults to quit both smoking and vaping. The findings, published June 25, 2025, in the journal Nicotine and Tobacco Research, indicate that nicotine replacement therapy (NRT)—using products containing low, controlled doses of nicotine to keep cravings at bay—combined with simultaneous support to stop using cigarettes and e-cigarettes is effective in helping young adults quit smoking. The findings further suggest that pairing these tobacco cessation methods can enhance prolonged abstinence from tobacco products, improving young people’s health for the long term.
“This is the first trial of its kind in the U.S., and it’s some initial evidence that pharmacotherapy like nicotine replacement therapy is an effective approach for this population,” Klemperer said.
UVM is still looking for people who smoke and vape to participate in their ongoing study.